Are pharmacists the ultimate barrier to pharmacy practice change?

Canadian Pharmacists Journal

Volumn 143, Issue 1, 2010, Pages 37-42

  Rosenthal, Meagen ^a   Austin, Zubin ^b   Tsuyuki, Ross T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMBIGUITY; ATTITUDE TO CHANGE; CULTURAL FACTOR; MEDICAL PRACTICE; PHARMACIST; PHARMACIST ATTITUDE; PHYSICIAN; RESPONSIBILITY; REVIEW; RISK FACTOR;

EID: 75649110456     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.3821/1913-701X-143.1.37     Document Type: Review

References (49)

1. Canadian Pharmacists Association. Blueprint for pharmacy: designing the future together. Ottawa (ON): Canadian Pharmacists Association; 2008. Available: www.pharmacists.ca/content/about-cpha/whats-happening/cpha-in-action/pdf/ Blueprint-Vision.pdf (accessed Nov 3, 2009).
2. Cranor CW. Outcomes of the Asheville diabetes project. Pharm Times 1998;Suppl:19-25.
3. Willink DP, Isetts BJ. Becoming 'indispensable': developing innovative community pharmacy practices. J Am Pharm Assoc 2005;45(3):376-89.
4. Saini B, Krass I, Armour C. Specialization in asthma: current practice and future roles - a qualitative study of practicing community pharmacists. J Soc Adm Pharm 2001;18(5):169-77.
5. Power A, Johnson BJ, Diack HL, et al. Scottish pharmacists' view and attitudes towards continuing professional development. Pharm World Sci 2008;30:136-43.
6. Roberts AS, Benrimoj SI, Chen TF, et al. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm 2005;1:546-64.
7. Bell HM, McElnay JC, Hughes CM, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Adm Pharm 1998;15(4):284-95.
8. Perepelkin J, Dobson RT. A qualitative inquiry into the practice experiences of community pharmacy managers. Can Pharm J 2009;142(2):89-95.
9. Doering PL. Prescribing authority for pharmacists, Florida style: a home run or a swing and a miss? Ann Pharmacother 2007;41:1878-83.
10. Kroger E, Moisan J, Gregoire JP. Billing for cognitive services: understanding Quebec pharmacists' behavior. Ann Pharmacother 2000;34:309-16.
11. Chan P, Grindrod KA, Bougher D, et al. A systematic review of remuneration systems for clinical pharmacy care services. Can Pharm J 2008;141(2):102-12.
12. Bloor G, Dawson P. Understanding professional culture in organizational context. Organ Stud 1994;15(2):275-95.
13. Fein IA, Corrato RR. Clinical practice guidelines: culture eats strategy for breakfast, lunch, and dinner. Crit Care Med 2008;36(4):1360-1.
14. Kotter JP, Heskett JL. Corporate culture and performance. New York (NY): The Free Press; 1992.
15. Clark BE, Mount JK. Pharmacy service orientation: a measure of organizational culture in pharmacy. Res Social Adm Pharm 2006;2:110-28.
16. Mrtek RG, Catizone C. Pharmacy and the professions. In: Wertheimer AI, Smith MC, editors. Pharmacy practice: social and behavioral aspects. 3rd ed. Baltimore (MD): Williams and Wilkins; 1989. p. 23-41.
17. George J, Pfleger D, McCaig D, et al. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists. Pharm World Sci 2006;28:45-53.
18. Lau E, Dolovich L, Austin Z. Comparison of self, physician and simulated patient ratings of pharmacist performance in family practice simulator. J Interprof Care 2007;21(2):129-40.
19. Zellmer WA. Unresolved issues in pharmacy. Am J Health Syst Pharm 2005;62:259-65.
20. Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extend roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med 2001;53:943-55.
21. Brodie DC. Need for a theoretical base for pharmacy practice. In: Wertheimer AI, Smith MC, editors. Pharmacy practice: social and behavioral aspects. 3rd ed. Baltimore (MD): Williams and Wilkins; 1989. p. 81-8.
22. Briesacher B, Corey R. Patient satisfaction with pharmaceutical services at independent and chain pharmacies. Am J Health Syst Pharm 1997;54:531-6.
23. Lodwick AD, Sajbel TA. Patient and physician satisfaction with pharmacist-managed anticoagulation clinic: implications for managed care organizations. Manag Care 2000;9(2):47-50.
24. Garret DG, Bluml BM. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc 2005;45(2):130-7.
25. Matowe L, Abahussain EA, Al-Saffar N, et al. Physician's perceptions of pharmacists' professional duties in government hospitals in Kuwait. Med Princ Pract 2006;15:185-9.
26. Romanow R. Building on values: the future of health care in Canada. Saskatoon (SK): Commission on the Future of Health Care in Canada; 2002.
27. Morfitt GL, Paish S, Cross G, et al. Report of the pharmaceutical task force. 2008. Available: www.lifesciencesbc.ca/files/PDF/ PharmaceuticalTaskForceReport.pdf (accessed Nov 3, 2009).
28. Department of Health. Our health, our care, our say: a new direction for community services. 2006. Available: www.dh.gov. uk/prod-consum-dh/groups/dh- digitalassets/@dh/@en/documents/ digitalasset/dh-4127459.pdf (accessed Nov 4, 2009).
29. Austin Z, Gregory PAM, Martin JC. Negotiation of interprofessional culture shock: the experiences of pharmacists who become physicians. J Interprof Care 2007;21(1):83-93.
30. Sanghera N, Chan PY, Khaki ZF, et al. Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review. Drug Saf 2006;29(11):1031-47.
31. Tobin C, Giacomantonio N, Firth W. Pharmacist intervention in the Community Cardiovascular Hearts In Motion program: a key component for adherence to medication recommendations. Can Pharm J 2009;142(6):e27.
32. Holland R, Brooksby I, Lenaghan E, et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomized control trial. BMJ 2007;334(1098).
33. Charrois TL, Johnson JA, Blitz S, Tsuyuki RT. Relationship between number, timing and type of pharmacist interventions and patient outcomes. Am J Health Syst Pharm 2005;62:1798-801.
34. Cooper RJ, Lynn J, Anderson C, et al. Learning to prescribe - pharmacists' experiences of supplementary prescribing training in England. BMC Med Educ 2008;8(57). Available: www.biomedcentral.com/1472-6920/8/57 (accessed Nov 4, 2009).
35. Hassell K. RPSGB Register Analysis 2004. Manchester, UK: The University of Manchester; 2004.
36. Langton N, Robbins SP. Organizational behaviour. 4th ed. Toronto (ON): Prentice Hall; 2007.
37. Buerki RA, Vottero LD. Ethical responsibility in pharmacy practice. Madison (WI): American Institute of the History of Pharmacy; 1994.
38. McRobbie DSD. MPharm courses should concentrate on pharmacy practice. Pharm J 2004;272:802.
39. Shuck AA, Phillips CR. Assessing pharmacy students' learning styles and personality types: a ten-year analysis. Am J Pharm Educ 1999;63:27-33.
40. Jesson JK, Langley CA, Wilson KA, Hatfield K. Science or practice? UK undergraduate experiences and attitudes to the MPharm degree. Pharm World Sci 2006;28:278-83.
41. Adcock H. Workforce issue is worldwide. Pharm J 2004;272:582-3.
42. Kolb DA. Learning styles and disciplinary differences. In: Chickering AW, et al., editors. The modern American college: responding to the new realities of diverse students and a changing society. San Francisco (CA): Jossey Bass; 1981. p. 232-55.
43. Lowenthal W. Myers-Briggs type inventory preferences of pharmacy students and practitioners. Eval Health Prof 1994;17(1):22-42.
44. Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med 2009;169(8):757-63.
45. Brown JN, Barnes CL, Beasely B, et al. Effect of pharmacists on medication errors in an emergency department. Am J Health Syst Pharm 2008;65:330-3.
46. Gard PR. A behavioural approach to pharmacy practice. Oxford (UK): Blackwell Science; 2000.
47. Al Hamarneh YN, Crealey GE, Badri M, McElnay JC. Public knowledge and understanding of coronary heart disease (CHD). Int J Pharm Pract 2008;Suppl 3:C12-3.
48. Tully MP, Latif S, Cantrill JA, Parker D. Pharmacists' changing views of their supplementary prescribing authority. Pharm World Sci 2007;29:628-34.
49. McGuire R. Workplace cultures and pharmacy. Pharm J 2006;276:447-50.